Paper37475889
Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis.
Buijsers B and 9 others. Front Mol Biosci, 2023. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis. Papers, record 37475889. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37475889
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24177139 | Protective effects of fucoidan, a P- and L-selectin inhibitor, in murine acute pancreatitis. | Pancreas | 2014 | https://conductscience.org/library/papers/24177139 | PubMed |
| 2 | 20471412 | Structural studies on a novel fucogalactan sulfate extracted from the brown seaweed Laminaria japonica. | Int J Biol Macromol | 2010 | https://conductscience.org/library/papers/20471412 | PubMed |
| 3 | 23499528 | Versatile role of heparanase in inflammation. | Matrix Biol | 2013 | https://conductscience.org/library/papers/23499528 | PubMed |
| 4 | 22034636 | Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy. | J Am Soc Nephrol | 2012 | https://conductscience.org/library/papers/22034636 | PubMed |
| 5 | 20025596 | Therapeutic use of heparin beyond anticoagulation. | Curr Drug Discov Technol | 2009 | https://conductscience.org/library/papers/20025596 | PubMed |
| 6 | 23095131 | A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition. | J Transl Med | 2012 | https://conductscience.org/library/papers/23095131 | PubMed |
| 7 | 9645599 | Regulation of interleukin-8 binding and function by heparin and alpha2-macroglobulin. | Clin Exp Allergy | 1998 | https://conductscience.org/library/papers/9645599 | PubMed |
| 8 | 35370636 | Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35370636 | PubMed |
| 9 | 26064103 | Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review. | Adv Pharmacol Sci | 2015 | https://conductscience.org/library/papers/26064103 | PubMed |
| 10 | 12654635 | Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. | Am J Respir Cell Mol Biol | 2003 | https://conductscience.org/library/papers/12654635 | PubMed |
| 11 | 16056228 | Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. | Nat Immunol | 2005 | https://conductscience.org/library/papers/16056228 | PubMed |
| 12 | 17550924 | Expression of glomerular heparan sulphate domains in murine and human lupus nephritis. | Nephrol Dial Transplant | 2007 | https://conductscience.org/library/papers/17550924 | PubMed |
| 13 | 29934302 | The role of heparan sulfate in host macrophage infection by Leishmania species. | Biochem Soc Trans | 2018 | https://conductscience.org/library/papers/29934302 | PubMed |
| 14 | 37180718 | Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37180718 | PubMed |
| 15 | 35509442 | Heparan sulfate mimetic fucoidan restores the endothelial glycocalyx and protects against dysfunction induced by serum of COVID-19 patients in the intensive care unit. | ERJ Open Res | 2022 | https://conductscience.org/library/papers/35509442 | PubMed |
| 16 | 30546836 | Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. | Oncotarget | 2018 | https://conductscience.org/library/papers/30546836 | PubMed |
| 17 | 15569308 | Isolation and characterization of conditionally immortalized mouse glomerular endothelial cell lines. | Kidney Int | 2004 | https://conductscience.org/library/papers/15569308 | PubMed |
| 18 | 29290153 | The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies. | J Histochem Cytochem | 2018 | https://conductscience.org/library/papers/29290153 | PubMed |
| 19 | 9651386 | Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9651386 | PubMed |
| 20 | 35500767 | Protective effects of fucoidan against kidney diseases: Pharmacological insights and future perspectives. | Int J Biol Macromol | 2022 | https://conductscience.org/library/papers/35500767 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41272309 | The glomerular endothelial glycocalyx as a therapeutic target in proteinuric kidney disease. | Nat Rev Nephrol | 2026 | https://conductscience.org/library/papers/41272309 | PubMed |
| 39975672 | Comprehensive management application of sulodexide on proteinuria: 2 case reports. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/39975672 | PubMed |
| 39885987 | Factors influencing glycocalyx degradation: a narrative review. | Front Immunol | 2024 | https://conductscience.org/library/papers/39885987 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37475889
GET https://conductscience.org/api/papers/v1/37475889/references?page=2